8 Aug 2018

Transparency notifications BlackRock, Inc.

Read More
3 Aug 2018

Transparency notifications BlackRock, Inc.

Read More
25 Jul 2018

UCB Half Year Report 2018: UCB continues its growth path

Read More
24 Jul 2018

Transparency notifications BlackRock, Inc.

Read More
12 Jul 2018

UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM (Romosozumab) to the U.S. FDA

Read More
12 Jul 2018

Transparency notification 

Read More
6 Jul 2018

Transparency notifications BlackRock, Inc.

Read More
2 Jul 2018

UCB announces approval of NEUPRO® in China to treat Parkinson’s Disease

Read More
27 Jun 2018

New UCB Research Showcases Value of CIMZIA® (certolizumab pegol) in Psoriasis and Highlights Unique Experiences and Real World Evidence for Key Patient Populations 

Read More
14 Jun 2018

New Study Presented at the Annual European Congress of Rheumatology (EULAR 2018) Reveals Insights About Women with Chronic Rheumatic Diseases During Their Pregnancy Journey 

Read More
Subscribe to